Patel V, Lee S, McPhail M, Da Silva K, et al. Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. J Hepatol 2021 Sep 24. pii: S0168-8278(21)02040.
PMID: 34571050